6OVQ image
Deposition Date 2019-05-08
Release Date 2019-11-27
Last Version Date 2023-10-11
Entry Detail
PDB ID:
6OVQ
Keywords:
Title:
Crystal structure of mithramycin 3-side chain keto-reductase MtmW
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
I 4
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Putative Side chain reductase
Chain IDs:A, B
Chain Length:333
Number of Molecules:2
Biological Source:Streptomyces argillaceus
Ligand Molecules
Primary Citation
Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis.
Angew.Chem.Int.Ed.Engl. 59 826 832 (2020)
PMID: 31702856 DOI: 10.1002/anie.201910241

Abstact

MtmOIV and MtmW catalyze the final two reactions in the mithramycin (MTM) biosynthetic pathway, the Baeyer-Villiger opening of the fourth ring of premithramycin B (PMB), creating the C3 pentyl side chain, strictly followed by reduction of the distal keto group on the new side chain. Unexpectedly this results in a C2 stereoisomer of mithramycin, iso-mithramycin (iso-MTM). Iso-MTM undergoes a non-enzymatic isomerization to MTM catalyzed by Mg2+ ions. Crystal structures of MtmW and its complexes with co-substrate NADPH and PEG, suggest a catalytic mechanism of MtmW. The structures also show that a tetrameric assembly of this enzyme strikingly resembles the ring-shaped β subunit of a vertebrate ion channel. We show that MtmW and MtmOIV form a complex in the presence of PMB and NADPH, presumably to hand over the unstable MtmOIV product to MtmW, yielding iso-MTM, as a potential self-resistance mechanism against MTM toxicity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures